![]() |
市場調査レポート
商品コード
1548849
骨成長刺激装置の市場規模、シェア、成長分析:用途別、エンドユーザー別、製品別、地域別- 産業予測、2024年~2031年Bone Growth Stimulators Market Size, Share, Growth Analysis, By Application, By End User, By Product, By Region - Industry Forecast 2024-2031 |
||||||
|
骨成長刺激装置の市場規模、シェア、成長分析:用途別、エンドユーザー別、製品別、地域別- 産業予測、2024年~2031年 |
出版日: 2024年08月29日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
骨成長刺激装置の世界市場規模は、2022年に21億米ドルと評価され、予測期間中(2024-2031年)のCAGRは4.9%で、2023年の22億米ドルから2031年には32億3,000万米ドルに成長する見通しです。
骨成長刺激は、特に骨折の治癒を助ける補完療法として広く認知されるようになった。これらの刺激装置は、骨折が自然治癒しない場合に一般的に使用されます。世界中で骨折やスポーツ関連傷害の発生率が増加していることが、これらの装置に対する需要の増加を促しています。全米脊髄損傷統計センター(NSCISC)によると、米国では毎年100万人当たり約54件の脊髄損傷が新たに発生しています。世界全体では、国立生物工学情報センター(National Centre for Biotechnology Information)の最近の報告書によると、年間25万人から50万人が脊髄損傷に苦しんでいると推定されています。骨成長刺激技術は整形外科手術を著しく進歩させ、骨形態形成タンパク質に関する数多くの臨床研究をもたらしました。これらの刺激装置は、脊椎固定、歯科、顎顔面外科、骨折修復など、さまざまな分野で広く利用されています。骨成長刺激装置市場は、変形性関節症や変性骨疾患の有病率の上昇により拡大しています。さらに、市場の成長は、治癒結果の向上に寄与する多血小板血漿や骨形態形成タンパク質の採用増加によって支えられています。
Global Bone Growth Stimulators Market size was valued at USD 2.10 Billion in 2022 and is poised to grow from USD 2.20 billion in 2023 to USD 3.23 billion by 2031, at a CAGR of 4.9% during the forecast period (2024-2031).
Bone growth stimulation has become a widely recognized complementary therapy, especially for aiding the healing of bone fractures. These stimulators are commonly used when fractures fail to heal on their own. The growing incidence of bone fractures and sports-related injuries worldwide is driving increased demand for these devices. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 54 new cases of spinal cord injury occur per million people in the United States each year. Globally, a recent report from the National Centre for Biotechnology Information estimates that between 250,000 and 500,000 individuals suffer from spinal cord injuries annually. Bone growth stimulation technology has significantly advanced orthopedic surgeries, leading to numerous clinical studies on bone morphogenetic proteins. These stimulators are widely utilized in various fields, including spinal fusion, dentistry, maxillofacial surgery, and fracture repair. The market for bone growth stimulators is expanding due to the rising prevalence of osteoarthritis and degenerative bone conditions. Additionally, the growth of the market is supported by the increasing adoption of platelet-rich plasma and bone morphogenetic proteins, which contribute to enhanced healing outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bone Growth Stimulators market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bone Growth Stimulators Market Segmental Analysis
The global bone growth stimulators market is segmented based on product type, application, end user and region. Based on product type, the market is segmented into bone growth stimulation devices {external bone growth stimulators (ultrasonic bone growth stimulators, and implanted bone growth stimulators)}, bone morphogenetic proteins, and platelet-rich plasma. Based on application, the market is segmented into spinal fusion surgeries, delayed union & non-union bone fractures, oral & maxillofacial surgeries, and others. Based on end user, the market is segmented into hospitals & ambulatory surgical centers, home care settings, and academic & research institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Bone Growth Stimulators Market
The increasing incidence of orthopedic conditions, including fractures, delayed unions, non-unions, and osteoporosis-related fractures, is a major factor driving the bone growth stimulators market. As the population ages and the frequency of orthopedic issues rises, the need for effective bone growth solutions is growing. With the aging demographic and the corresponding rise in orthopedic conditions, there is a heightened demand for bone growth stimulators. This growing need reflects the broader trend of addressing and managing various bone health challenges that come with advancing age.
Restraints in the Global Bone Growth Stimulators Market
Although bone growth stimulators are typically deemed safe, there are potential side effects and risks to be aware of. These may include skin irritation, allergic reactions, and discomfort during the treatment process. Such concerns about possible adverse effects might discourage some patients and healthcare providers from opting for bone growth stimulators. The potential for these side effects can influence decisions regarding their use in managing bone health and healing.
Market Trends of the Global Bone Growth Stimulators Market
Currently, the bone growth stimulators industry is being shaped by several significant developments. A notable trend is the growing demand for patient-friendly and minimally invasive treatments. Bone growth stimulators are increasingly favored by both healthcare providers and patients as they offer a less intrusive alternative to traditional surgical methods, promoting bone healing effectively. This preference for less invasive options is especially evident in the treatment of orthopedic conditions such as spinal fusion and fractures. The shift towards bone growth stimulators reflects a broader movement towards more accessible and less disruptive treatment solutions in the field of orthopedic care.